Events

Sign Up To Attend Free ODAC Virtual Workshops

By January 13, 2021No Comments

Dermatology Events

Events

Sign up now to attend Free ODAC Virtual 2021 Workshops

Sign up now to attend Free ODAC Virtual 2021 Workshops

The virtual ODAC conference, taking place January 14 – 17, 2021 is offering free workshops throughout the week.

Dermatologists do not need to be registered to attend ODAC to join the workshops, however, to attend, you must preregister for each session. View the workshop agenda below to save your spot.

To view the entire ODAC Conference agenda, click here.

  • In His Own Words: One Patient’s Journey with Dr. Alvaro Moreira

  • Wednesday, January 13th 7:00 PM ET
Sign Up Now
  • FDA Approved Label Expansion. Progress Your Topical Patients to the Next Step: An Oral Treatment With Data for Moderate to Severe Scalp Psoriasis with Lawrence Green, MD

  • Thursday, January 14th 7:15 PM ET
Sign Up Now
  •  ARAZLO™ Lotion: Tazarotene Redefined with Leon Kircik, MD

  • Friday, January 15th 12:00 PM ET
Sign Up Now
  • Behind the Brand – The DNA of La Roche-Posay with Adam Friedman, MD

  • Friday, January 15th 3:15 PM ET
Sign Up Now
  • Pathophysiology of Atopic Dermatitis with Marc Serota, MD, FAAD

  • Saturday, January 16th 12:00 PM ET
Sign Up Now

You May Also Like

Journal of Drugs in Dermatology JDD Article About Looking for Curated Atopic Derm Content? We’ve Got You Covered.

Looking for Curated Atopic Derm Content? We’ve Got You Covered!

| Atopic Dermatitis, Featured Articles, Latest News, The Latest | No Comments
Explore JDDonline If you’re on the hunt for expert-led, handpicked resources on atopic dermatitis, you’re in the right place. Whether you're brushing up on the latest treatment insights or looking…
Journal of Drugs in Dermatology JDD Article About Rituximab in the Treatment of Epidermolysis Bullosa Acquisita: A Systematic Review of the Literature

Rituximab in the Treatment of Epidermolysis Bullosa Acquisita: A Systematic Review of the Literature

| Featured Articles, Latest News, The Latest | No Comments
Could Rituximab Be the Key to Managing Epidermolysis Bullosa Acquisita? Epidermolysis bullosa acquisita (EBA) is a rare and often debilitating autoimmune blistering disease that remains notoriously difficult to manage. While…
Journal of Drugs in Dermatology JDD Article About An Innovative Cream Improves Signs and Symptoms of Dermatoporosis in Patients Aged 65 and Over

An Innovative Cream Improves Signs and Symptoms of Dermatoporosis in Patients Aged 65 and Over

| Featured Articles, Latest News, The Latest | No Comments
A Breakthrough Approach to Aging Skin: Can This Cream Combat Dermatoporosis? As skin ages, it becomes fragile, thin, and prone to bruising - a condition known as dermatoporosis, which is…

Leave a Reply